The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2014

Filed:

Jul. 16, 2010
Applicants:

Gary L. Cantrell, Troy, IL (US);

Raghavan Rajagopalan, St. Peters, MO (US);

David W. Berberich, St. Peters, MO (US);

Amolkumar Karwa, St. Charles, MO (US);

Richard B. Dorshow, St. Louis, MO (US);

Inventors:

Gary L. Cantrell, Troy, IL (US);

Raghavan Rajagopalan, St. Peters, MO (US);

David W. Berberich, St. Peters, MO (US);

Amolkumar Karwa, St. Charles, MO (US);

Richard B. Dorshow, St. Louis, MO (US);

Assignee:

Mallinckrodt LLC, Hazelwood, MO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/485 (2006.01); A61K 31/472 (2006.01); A61K 9/00 (2006.01); A61K 9/02 (2006.01); A61K 9/10 (2006.01); A61K 9/14 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 41/00 (2006.01); A61K 45/06 (2006.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 31/472 (2013.01); A61K 9/0075 (2013.01); A61K 9/02 (2013.01); A61K 9/10 (2013.01); A61K 9/145 (2013.01); A61K 9/2009 (2013.01); A61K 9/2022 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 31/485 (2013.01); A61K 41/0057 (2013.01); A61K 45/06 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01);
Abstract

The invention relates generally to anti-angiogenesis agents and related methods of using to anti-angiogenesis agents for biomedical applications including direct monotherapy and combination therapy for treatment of an angiogenesis related condition. In an embodiment, the invention provides a class of opioid compounds and structurally related opioid derivatives exhibiting anti-VEGF activity for use in therapeutic procedures, including phototherapy. Opioid compounds and structurally related opioid derivatives of the invention may be administered alone or in combination with administration of a phototherapy agent and/or other therapeutic agent.


Find Patent Forward Citations

Loading…